The use of bioabsorbable vascular scaffolds (BVS) in patients with critical limb-threatening ischemia (CLTI) results in durable patency out to 24 months, with a high rate of freedom from major ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 2 years after implantation, a fully bioresorbable ...
WASHINGTON, DC — Patients who received the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) in the ABSORB-3 trial showed a primary outcome, counting only events occurring between the ...
Please provide your email address to receive an email when new articles are posted on . In the investigator-initiated AIDA trial, a bioresorbable vascular scaffold conferred similar risk for target ...
Bioresorbable vascular scaffolds (BVS) are the latest innovation in the field of coronary interventions and are emerging as a promising treatment for patients with coronary artery stenoses Available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results